Integrity Researchwatch has moved to
http://www.integrity-research.com/cms/researchwatch
Please update your bookmarks.



Subscribe to Integrity ResearchWatch by Email
or  in an RSS/XML reader

For those of you who don't know about Integrity Research Associates, we publish syndicated research reports; provide an online database of reviews, analysis and ratings on research firms; and offer specialized consulting about the equity research industry for professionals at money management, hedge fund, and broker / dealer firms. You can learn more about our company and our products / services at www.integrity-research.com.


Please feel free to contact us about our company, our products, or our services using the contact information below.
Integrity Research Associates, LLC
1115 Broadway, 12th Floor
New York, NY 10010

Tel: 212-845-9088
Fax: 212-845-9091
E-Mail: info@integrity-research.com
URL: www.integrity-research.com

Investorside Research Association


<< April 2008 >>
Sun Mon Tue Wed Thu Fri Sat
 01 02 03 04 05
06 07 08 09 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30


If you want to be updated on this weblog Enter your email here:






Thursday, April 03, 2008
Gradient is Vindicated in Biovail Mess

New York - One of the firms implicated in the Biovail lawsuits of recent years was research provider Gradient Analytics. Biovail had sued Gradient for undermining the value of its stock, by releasing research reports that were purportedly designed to prey on the value of Biovail stock. A recent story covers the salient facts that were uncovered by a recent SEC investigation into both Biovail and Gradient and was published in an article by Trading markets.com.

Gradient has had a difficult time over the past several years, vigorously defending itself  on one hand and beefing up its policies and procedures on the other.

As it turns out, the charges by Biovail look more like they are based on the vengeful rantings of a litigous Biovail CEO instead of having any basis in fact. Indeed, the article points out that Gradient had acurately pointed out the facts of the Biovailaccounting inconsistencies before the SEC investigation led to the conclusion that improprieties had been committed by the Biovail.

Of the three accounting fraud charges against Biovail, Gradient wrote about two, beginning in December 2002. Gradient also wrote about the truck-accident incident, which Bank of America analyst Dave Maris questioned in his first report on Biovail in October 2003. The other charge, a "phony bill and hold transaction" also was reflected in the unusual trends in accounts receivable noted by Gradient at the time. threats by Biovail CEO caused Banc of America to drop coverage of Biovail.

It was Gradient's Earnings Quality Model (EQM) that identified the accounting issues. This software also enables users to explore Gradient's proprietary database of earnings quality information using screening features and set preferences for notification of any updates on any company in their portfolio.

Also of interest is Gradient's subscription Equity Incentive Model (EIM) which enables users to explore Gradient's proprietary database of information pertaining to equity compensation issues.

Posted at 09:13 am by Thomas Hutchinson
Make a comment  

Previous Page Next Page